VRSN
64
-2
LRCX
74
3
AAL
44
6
CAG
41
-2
AES
62
4
CB
51
-6
F
54
-6
WAT
55
-4
MAT
65
2
ALLE
60
-4
AMZN
66
2
CHD
40
-2
CCL
81
3
ITW
48
-2
GIS
41
-2
TGT
50
-3
D
38
-5
ACN
65
2
PNW
49
-6
PCG
72
-5
VRSN
64
-2
LRCX
74
3
AAL
44
6
CAG
41
-2
AES
62
4
CB
51
-6
F
54
-6
WAT
55
-4
MAT
65
2
ALLE
60
-4
AMZN
66
2
CHD
40
-2
CCL
81
3
ITW
48
-2
GIS
41
-2
TGT
50
-3
D
38
-5
ACN
65
2
PNW
49
-6
PCG
72
-5
Financhill
Back

Alnylam Pharmaceuticals Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
51

ALNY
Alnylam Pharmaceuticals

Last Price:
$267.62
Seasonality Move:
25.91%
Sell
42

SRPT
Sarepta Therapeutics

Last Price:
$35.78
Seasonality Move:
13.8%
Buy
51
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $267.55. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $36.20. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $267.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $36.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.08 Buy
Relative Strength Index (14 RSI): 55.61 Buy
Chaikin Money Flow: 279299 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (236.08 - 265.74) Buy
Bollinger Bands (100): (237.75 - 269.03) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.97 Sell
Relative Strength Index (14 RSI): 22.77 Sell
Chaikin Money Flow: 421748 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 266.75 Buy
20-day SMA: 254.73 Buy
50-day SMA: 252.76 Buy
200-day SMA: 259.57 Buy
8-day EMA: 264.34 Buy
20-day EMA: 258.59 Buy
50-day EMA: 254.9 Buy
200-day EMA: 246.43 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.5 Sell
20-day SMA: 53.1 Sell
50-day SMA: 67.21 Sell
200-day SMA: 110.18 Sell
8-day EMA: 42.66 Sell
20-day EMA: 50.94 Sell
50-day EMA: 65.94 Sell
200-day EMA: 99.51 Sell

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.15 per share, an increase next quarter of $1.52 per share, an increase this year of $1.31 per share, and an increase next year of $2.89 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.81 per share, an increase next quarter of $0.87 per share, a decrease this year of $3.97 per share, and an increase next year of $8.43 per share.

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):